Neftaly: The Role of Biomarkers in Strengthening Health Systems Resilience
Introduction
Resilient health systems are those that can anticipate, respond to, and recover from shocks—whether pandemics, climate disasters, or chronic disease burdens—while continuing to provide essential services. One of the most underutilized tools in building such resilience is the biomarker.
Biomarkers—objective indicators of biological states—offer real-time, evidence-based insights that can guide better planning, response, and long-term system strengthening. At Neftaly, we advocate for the strategic integration of biomarkers to enhance the agility, adaptability, and preparedness of health systems in Africa and beyond.
How Biomarkers Contribute to Health System Resilience
1. Early Detection and Surveillance
- Biomarkers enable early identification of disease outbreaks (e.g. C-reactive protein in sepsis, PCR for viral infections).
- Biomarker-based screening improves timely diagnosis of chronic and infectious diseases, reducing system strain during crises.
2. Monitoring System Stress and Recovery
- In post-crisis contexts (e.g., pandemics or natural disasters), biomarkers can track:
- Population health recovery (e.g., nutritional markers after food insecurity)
- Health workforce well-being (e.g., stress and fatigue biomarkers)
- These data help health leaders assess how quickly services and outcomes are returning to baseline.
3. Strengthening Primary Health Care
- Integrating point-of-care biomarker testing into primary care boosts early intervention, reducing hospital burden.
- Biomarkers such as HbA1c for diabetes or ALT/AST for liver function ensure quality and continuity of chronic care, even during emergencies.
4. Supporting Targeted Resource Allocation
- Biomarker data helps prioritize interventions and resource distribution based on real-time health risks, not just static indicators.
- Enables risk stratification, allowing vulnerable populations to be identified and supported early.
5. Informing Resilient Policy and Preparedness Planning
- By tracking long-term biomarker trends, governments can:
- Model future health risks
- Evaluate preparedness levels
- Adjust national health policies based on evidence from biomarker data
Best Practices for Leveraging Biomarkers for Resilience
- Integrate Biomarkers into National Resilience Frameworks
Include biomarker data in health emergency preparedness plans and routine system assessments. - Ensure Data Infrastructure and Interoperability
Biomarker results must flow into national health information systems for timely analysis and response. - Promote Decentralized Testing and Diagnostics
Equip community-level facilities with biomarker-based diagnostics to improve frontline response capacity. - Standardize and Regulate Biomarker Use
Adopt validated protocols to ensure biomarker reliability, accuracy, and ethical use. - Invest in Training and Capacity Building
Train health workers and analysts to collect, interpret, and act on biomarker data for better crisis response.
Neftaly’s Commitment
At Neftaly, we help countries harness biomarkers to build more resilient health systems by:
- Supporting national strategies to integrate biomarkers into surveillance and preparedness plans
- Training programs for public health officials, lab technicians, and policymakers
- Providing technical assistance for biomarker data integration and analysis
- Facilitating multi-stakeholder collaboration to promote innovation, equity, and sustainability
Conclusion
Biomarkers are more than diagnostic tools—they are strategic assets for resilient health systems. They offer actionable data that can shape faster responses, stronger recovery, and smarter planning in times of crisis and stability alike.